Krebs Biochemicals & Industries Intrinsic Value
KREBSBIO Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Revenue Multiple Method | revenue | ₹25.45 | ₹22.91 - ₹28.00 | -62.0% | Revenue/Share: ₹12.73, P/S: 2.0x |
Want to compare with current market value? Check KREBSBIO share price latest .
Valuation Comparison Chart
KREBSBIO Intrinsic Value Analysis
What is the intrinsic value of KREBSBIO?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Krebs Biochemicals & Industries (KREBSBIO) is ₹25.45 (median value). With the current market price of ₹66.91, this represents a -62.0% variance from our estimated fair value.
The valuation range spans from ₹25.45 to ₹25.45, indicating ₹25.45 - ₹25.45.
Is KREBSBIO undervalued or overvalued?
Based on our multi-method analysis, Krebs Biochemicals & Industries (KREBSBIO) appears to be trading above calculated value by approximately 62.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.05 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | -1.16 | Industry Standard: <0.5 | Below 0.5 | Indicates financial leverage level |
| Return on Equity | 18.5% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | -59.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.17x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Krebs Biochemicals & Industries
Additional stock information and data for KREBSBIO
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-8 Cr | ₹-11 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹2 Cr | ₹-2 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹-25 Cr | ₹-32 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-17 Cr | ₹-29 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-15 Cr | ₹-27 Cr | Negative Cash Flow | 3/10 |